Similarly, a CCL7 neutralizing antibody has been shown to inhibit CCL7-induced invasion and migration of oral carcinoma cells [50], and anti-CCL2 and-CCR3 antibodies are also being evaluated [50, 60]. This evidence concerns the gene CCR3 and lip and oral cavity carcinoma.